The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
18F-FDG brain PET hypometabolism in patients with long COVID
Open accessAbstract
In the context of the worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), some patients report functional complaints after apparent recovery from COVID-19. This clinical presentation has been referred as “long COVID.” We here present a retrospective analysis of 18F-FDG brain PET of long COVID patients from the same center with a biologically confirmed diagnosis of SARS-CoV-2 infection and persistent functional complaints at least 3 weeks after the initial infection. PET scans of 35 patients with long COVID were compared using whole-brain voxel-based analysis to a local database of 44 healthy subjects controlled for age and sex to characterize cerebral hypometabolism. The individual relevance of this metabolic profile was evaluated to classify patients and healthy subjects. Finally, the PET abnormalities were exploratory compared with the patients’ characteristics and functional complaints. In comparison to healthy subjects, patients with long COVID exhibited bilateral hypometabolism in the bilateral rectal/orbital gyrus, including the olfactory gyrus; the right temporal lobe, including the amygdala and the hippocampus, extending to the right thalamus; the bilateral pons/medulla brainstem; the bilateral cerebellum (p-voxel < 0.001 uncorrected, p-cluster < 0.05 FWE-corrected). These metabolic clusters were highly discriminant to distinguish patients and healthy subjects (100% correct classification). These clusters of hypometabolism were significantly associated with more numerous functional complaints (brainstem and cerebellar clusters), and all associated with the occurrence of certain symptoms (hyposmia/anosmia, memory/cognitive impairment, pain and insomnia) (p < 0.05). In a more preliminary analysis, the metabolism of the frontal cluster which included the olfactory gyrus was worse in the 7 patients treated by ACE drugs for high blood pressure (p = 0.032), and better in the 3 patients that had used nasal decongestant spray at the infectious stage (p < 0.001). This study demonstrates a profile of brain PET hypometabolism in long COVID patients with biologically confirmed SARS-CoV-2 and persistent functional complaints more than 3 weeks after the initial infection symptoms, involving the olfactory gyrus and connected limbic/paralimbic regions, extended to the brainstem and the cerebellum. These hypometabolisms are associated with patients’ symptoms, with a biomarker value to identify and potentially follow these patients. The hypometabolism of the frontal cluster, which included the olfactory gyrus, seems to be linked to ACE drugs in patients with high blood pressure, with also a better metabolism of this olfactory region in patients using nasal decongestant spray, suggesting a possible role of ACE receptors as an olfactory gateway for this neurotropism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30203-0 · Cited by 2,407
Baig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00122 · Cited by 2,207
Nervous system involvement after infection with COVID-19 and other coronaviruses
Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C., & Yang, C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.03.031 · Cited by 2,046
Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors
Mazza, M. G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., Melloni, E. M. T., Furlan, R., Ciceri, F., Rovere-Querini, P., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.037 · Cited by 1,804
Troyer, E. A., Kohn, J. N., & Hong, S. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.027 · Cited by 964 · cited 1×
“These presentations have been also related to the quarantine, possible adverse effects of treatments such as corticosteroids [2], or traumatic experience of media exposure or hospitalization with uncertainty regarding the prognosis [25].”
BackgroundMoldofsky, H., & Patcai, J. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-37 · Cited by 604 · cited 1×
“post-traumatic stress disorder in the post-illness stage [23], with a chronic fatigue syndrome and fibromyalgia association [24].”
BackgroundHanley, B., Naresh, K. N., Roufosse, C., Nicholson, A. G., Weir, J., Cooke, G. S., Thursz, M., Manousou, P., Corbett, R., Goldin, R., et al. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30115-4 · Cited by 535
Consensus Paper: Revisiting the Symptoms and Signs of Cerebellar Syndrome
Bodranghien, F., Bastian, A., Casali, C., Hallett, M., Louis, E. D., Manto, M., Mariën, P., Nowak, D. A., Schmahmann, J. D., Serrao, M., et al. (2016) · The Cerebellum · doi:10.1007/s12311-015-0687-3 · Cited by 384
Liao, X., Wang, B., & Kang, Y. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05954-2 · Cited by 266
Lancet, T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32662-3 · Cited by 251
Psychological distress related to COVID-19 – The contribution of continuous traumatic stress
Lahav, Y. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.141 · Cited by 217
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
Liguori, C., Pierantozzi, M., Spanetta, M., Sarmati, L., Cesta, N., Iannetta, M., Ora, J., Mina, G. G., Puxeddu, E., Balbi, O., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.037 · Cited by 212
Guedj, E., Million, M., Dudouet, P., Tissot-Dupont, H., Bregeon, F., Cammilleri, S., & Raoult, D. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04973-x · Cited by 185
Self-citationSerrano-Castro, P. J., Estivill-Torrús, G., Cabezudo-García, P., Reyes-Bueno, J. A., Ciano Petersen, N., Aguilar-Castillo, M. J., Suárez-Pérez, J., Jiménez-Hernández, M. D., Moya-Molina, M. Á., Oliver-Martos, B., et al. (2020) · Neurología · doi:10.1016/j.nrl.2020.04.002 · Cited by 168
Canto, C. B., Onuki, Y., Bruinsma, B., van der Werf, Y. D., & De Zeeuw, C. I. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.03.001 · Cited by 163
How the motor system integrates with working memory
Marvel, C. L., Morgan, O. P., & Kronemer, S. I. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.017 · Cited by 151
Morbelli, S. D., Drzezga, A. E., Perneczky, R., Frisoni, G. B., Caroli, A., van Berckel, B. N. M., Ossenkoppele, R., Guedj, É., Didic, M., Brugnolo, A., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.01.005 · Cited by 139
The Pain Imaging Revolution: Advancing Pain Into the 21st Century
Borsook, D., Sava, S., & Becerra, L. R. (2010) · The Neuroscientist · doi:10.1177/1073858409349902 · Cited by 114
Grimaldi, S., Lagarde, S., Harlé, J., Boucraut, J., & Guedj, É. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.249292 · Cited by 103
Breast scintigraphy: procedure guidelines for tumour imaging
Bombardieri, E., Aktolun, C., Baum, R. P., Bishof-Delaloye, A., Buscombe, J. R., Chatal, J. F., Maffioli, L. S., Moncayo, R., Mortelmans, L., & Reske, S. N. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1354-3 · Cited by 90
Meeting the challenge of long COVID
(2020) · Nature Medicine · doi:10.1038/s41591-020-01177-6 · Cited by 75
Mainland, J. D., Johnson, B. N., Khan, R. R., Ivry, R. B., & Sobel, N. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0920-05.2005 · Cited by 71
Clinical Correlate of Brain SPECT Perfusion Abnormalities in Fibromyalgia
Guedj, É., Cammilleri, S., Niboyet, J., Dupont, P., Vidal, E., Dropinski, J.-P., & MUNDLER, O. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.053264 · Cited by 60
Self-citationTransient hemiageusia in cerebrovascular lateral pontine lesions
Landis, B. N. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.086801 · Cited by 51
Guedj, É., Barbeau, E. J., Didic, M., Félician, O., de Laforte, C., Ranjeva, J., Poncet, M., Cozzone, P. J., MUNDLER, O., & Ceccaldi, M. P. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1060-x · Cited by 42
Self-citationCoronaviruses and Central Nervous System Manifestations
Khateb, M., Bosak, N., & Muqary, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00715 · Cited by 39
COVID-19 and the brain: impact on nuclear medicine in neurology
Morbelli, S. D., Ekmekçioğlu, Ö., Barthel, H., Albert, N. L., Boellaard, R., Cecchin, D., Guedj, É., Lammertsma, A. A., Law, I. G., Peñuelas, I., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04965-x · Cited by 25
Cited by
Long COVID: major findings, mechanisms and recommendations
Davis, H. E., McCorkell, L., Vogel, J. M., & Topol, E. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00846-2 · Cited by 4,153
Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis
Ceban, F., Ling, S., Lui, L. M. W., Lee, Y., Gill, H., Teopiz, K. M., Rodrigues, N. B., Subramaniapillai, M., Di Vincenzo, J. D., Cao, B., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.12.020 · Cited by 1,554
Pathophysiology and mechanism of long COVID: a comprehensive review
Castanares-Zapatero, D., Chalon, P., Kohn, L., Dauvrin, M., Detollenaere, J., Maertens de Noordhout, C., Primus-de Jong, C., Cleemput, I., & Van den Heede, K. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2076901 · Cited by 585
Greene, C., Connolly, R., Brennan, D., Laffan, A., O’Keeffe, E., Zaporojan, L., O’Callaghan, J., Thomson, B., Connolly, E., Argue, R., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01576-9 · Cited by 429
Song, W.-J., Hui, C. K. M., Hull, J. H., Birring, S. S., McGarvey, L., Mazzone, S. B., & Chung, K. F. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00125-9 · Cited by 372
Metadata
- Authors
- Guedj, E., Campion, J. Y., Dudouet, P., Kaphan, E., Bregeon, F., Tissot-Dupont, H., Guis, S., Barthelemy, F., Habert, P., Ceccaldi, M., Million, M., Raoult, D., Cammilleri, S., & Eldin, C.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2021-01-26
- Volume
- 48
- Issue
- 9
- Pages
- 2823-2833
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W3125396713
- Cited by
- 459
- References
- 28
- FWCI
- 39.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.